ILMN
HEALTHCAREIllumina Inc
$142.58+3.51 (+2.52%)PRE
Live · NASDAQ · May 9, Close
AI Insight
What's Moving ILMN Today?
No stock-specific AI insight has been generated for ILMN yet. Check back soon — insights are generated from recent news analysis.
52-Week Range
$75.24$155.53
$142.58
Fundamentals
Market Cap$21.6B
P/E Ratio26.0
EPS$5.49
Dividend Yield—
Dividend / Share—
ROE0.3%
Profit Margin0.2%
Debt / Equity—
Trading
Volume1.3M
Avg Volume (10D)—
Shares Outstanding151.3M
ILMN News
27 articles- BSX Q1 Neuromodulation Sales Rise 15% Y/Y: What Lies Behind the Growth?Yahoo Finance·May 8, 2026
- Pacific Biosciences of California Q1 Earnings Call HighlightsMarketbeat·May 8, 2026
- Why The Dip In TEM Stock Is A Buying WindowTrefis·May 6, 2026
- Assessing Illumina (ILMN) Valuation After Earnings Beat Guidance Hike And Expanded BuybackYahoo Finance·May 5, 2026
- PacBio Pre-Q1 Analysis: Time to Buy, Hold or Sell the Stock Now?Yahoo Finance·May 5, 2026
- [Latest] Global Targeted DNA RNA Sequencing Market Size/Share Worth USD 46.9 Billion by 2035 at a 18.5% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)Yahoo Finance·May 4, 2026
- ILMN Q1 Deep Dive: Clinical Sequencing Fuels Growth as NovaSeq X Demand SurgesYahoo Finance·May 3, 2026
- ILMN Stock Up on Q1 Earnings & Revenue Beat, Margins Expand, '26 View UpYahoo Finance·May 1, 2026
- Illumina, Inc. Q1 2026 Earnings Call SummaryMoby·May 1, 2026
- Illumina Inc (ILMN) Q1 2026 Earnings Call Highlights: Strong Revenue Growth and Raised Guidance ...Yahoo Finance·May 1, 2026
- Illumina (ILMN) Q1 Earnings: Taking a Look at Key Metrics Versus EstimatesYahoo Finance·May 1, 2026
- Illumina Q1 Earnings Call HighlightsMarketbeat·Apr 30, 2026
- Illumina (ILMN) Tops Q1 Earnings and Revenue EstimatesYahoo Finance·Apr 30, 2026
- Illumina (ILMN) Q1 2026 Earnings TranscriptMotley Fool·Apr 30, 2026
- Illumina (NASDAQ:ILMN) Posts Better-Than-Expected Sales In Q1 CY2026Yahoo Finance·Apr 30, 2026
- Illumina Reports Financial Results for First Quarter of Fiscal Year 2026Yahoo Finance·Apr 30, 2026
- Tempus AI vs. Illumina: Which Oncology Stock Is Worth Buying Now?Yahoo Finance·Apr 30, 2026
- Illumina (ILMN) Q1 Earnings Report Preview: What To Look ForYahoo Finance·Apr 29, 2026
- Will DRAGEN v4.5’s ML-Powered Genomics Upgrade Reshape Illumina’s (ILMN) Precision Medicine Narrative?Yahoo Finance·Apr 29, 2026
- Unlocking Q1 Potential of Illumina (ILMN): Exploring Wall Street Estimates for Key MetricsYahoo Finance·Apr 29, 2026
- Omics-Based Clinical Trials Research Report 2026: $47.78 Bn Market Opportunities, Trends, Competitive Landscape, Strategies, and Forecasts, 2020-2025, 2025-2030F, 2035FGlobeNewswire Inc.·Apr 24, 2026
- Metafoodx to Showcase Award-Winning AI Kitchen Intelligence Platform at the 2026 National Restaurant Association ShowGlobeNewswire Inc.·Apr 20, 2026
- Administrator Loeffler Applauds SBIR-STTR ReauthorizationGlobeNewswire Inc.·Apr 13, 2026
- Global Next-Generation Sequencing (NGS) Market to Double in Size by 2030 - Asia-Pacific NGS Market Poised for Fastest Growth, Driven by Large-Scale Genomic Projects and the Rising Need for Precision MedicineGlobeNewswire Inc.·Apr 10, 2026
- Global DNA Read, Write and Edit Market to Surge to $67.7 Billion by 2030, Driven by CRISPR Advances, Genomic Diagnostics and Expanding Clinical ApplicationsGlobeNewswire Inc.·Apr 7, 2026
- Molecular Diagnostics Market Size is Expected to Reach USD 43.50 Billion by 2035 Owing to the Surging Demand for Accurate and Early Disease Detection Globally | SNS InsiderGlobeNewswire Inc.·Apr 3, 2026
- Oncology Biomarkers Market Trends and Investment Opportunities Report 2026-2030: Global, Regional and Country-Level OutlookGlobeNewswire Inc.·Mar 30, 2026
All 27 articles loaded
Price Data
Open$0.00
Previous Close$139.07
Day High$0.00
Day Low$0.00
52 Week High$155.53
52 Week Low$75.24
52-Week Range
$75.24$155.53
$142.58
Fundamentals
Market Cap$21.6B
P/E Ratio26.0
EPS$5.49
Dividend Yield—
Dividend / Share—
ROE0.3%
Profit Margin0.2%
Debt / Equity—
Trading
Volume1.3M
Avg Volume (10D)—
Shares Outstanding151.3M
About Illumina Inc
Illumina, Inc. is an American company. Incorporated on April 1, 1998, Illumina develops, manufactures, and markets integrated systems for the analysis of genetic variation and biological function. The company provides a line of products and services that serves the sequencing, genotyping and gene expression, and proteomics markets. Its headquarters are located in San Diego, California.
HEALTHCAREDIAGNOSTICS & RESEARCH
Company Details
Security TypeStock
ExchangeNASDAQ
CurrencyUSD
Round Lot—
SICDIAGNOSTICS & RESEARCH
CIK—
Composite FIGI—
Share Class FIGI—